title: New radiotracers in gynecological cancer: beyond ¹⁸F-FDG.
abstract: Imaging plays an important role in the management of gynecological cancers. There is a clinical need for noninvasive prognostic biomarkers to provide more detailed tumor characterization at the baseline and/or early during therapy, which may potentially improve outcomes and enable a personalized treatment approach. Imaging parameters derived from PET/CT techniques are emerging as promising imaging biomarkers. This review details the current evidence and future potential of functional imaging using non-2-deoxy-2-[18F]fluoro-D-glucose (FDG) tracers in gynecological cancers.
authors: Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK - amarnath.challapalli@uhbristol.nhs.uk.
authors: Amarnath
authors: A
authors: Challapalli
mesh_terms: D000818:Animals; D003952:Diagnostic Imaging / Q000379:methods*; D005260:Female; D019788:Fluorodeoxyglucose F18; D005833:Genital Neoplasms, Female / Q000000981:diagnostic imaging* / Q000378:metabolism; D006801:Humans; D011849:Radioactive Tracers
chemical_list: D011849:Radioactive Tracers; D019788:Fluorodeoxyglucose F18